Dotmatics

Dotmatics
TypeSubsidiary
Industry
Founded2005; 21 years ago (2005)
Founders
  • Stephen Gallagher,
  • Alastair Hill
HeadquartersBoston, Massachusetts, USA
Key peopleBrian Lee (CEO)
Products
Number of employees
  • Steady 800 (2022)
ParentSiemens
Websitewww.dotmatics.com

Dotmatics is an R&D scientific software company used by scientists in the R&D process.

Founded in 2005, its primary office is in Boston with 14 offices around the globe. Dotmatics' software is used by 2 million scientists and researchers and 10,000 customers.

It offers a cloud-based data management platform to support the R&D process and a series of software applications used by scientists that include GraphPad Prism, SnapGene, Geneious Prime, Geneious Biologics, Lab Archives, OMIQ, Protein Metrics, nQuery, Cytapex Bioinformatics, De Novo, SoftGenetics, and M-Star.

In October 2023, Dotmatics released a multimodal drug discovery platform named Luma. Luma is a low-code SaaS platform that aggregates relevant data across instruments and software into clean data structures for AI and ML-based analysis.

In April 2025, Siemens announced it will acquire Dotmatics for $5.1B from Insight Partners. On July 1, 2025, it was announced that the purchase was completed.

History

Dotmatics' origins trace back to Merck Sharp and Dohme, a multinational pharmaceutical company, where, in the early 2000s, Merck staff developed what later became Dotmatics' browser and gateway software. Dotmatics Limited was founded in 2005 as a spin-out when Merck closed the site.

The company was established with the intent to address the information needs of scientists in the biotech/pharma space. At one point, it was backed by Insight Partners, a venture capital and private equity firm.

Software and use

Dotmatics develops web-based tools for querying, browsing, managing, and sharing scientific data and documents.

The Informatics Suite is all the software packaged into one integrated suite.

See also